FOI release

Case Reference: FOI2026/00246 Follow-up

Some or all of the information requested was not provided because we didn't hold it.

Case reference FOI2026/00773

Received 20 March 2026

Published 16 July 2026

Request

Dear Freedom of Information Team, Thank you for your email. I write further to your response to FOI2026/00246. In that response, the Trust stated: “During an NHSE AML MRD subgroup meeting in September 2021… it was stated that Superscript IV should not be used… This was included in AML MRD minimal technical standards.” As this indicates reliance on recorded information, I request disclosure of that information under the Freedom of Information Act 2000. Please provide: 1. Copies of any recorded information and/or document described as, or equivalent to, “AML MRD minimal technical standards” (draft or final) in which this statement and/or equivalent guidance appears. 2. Any recorded outputs from the NHS England AML MRD subgroup meeting in or around September 2021 (e.g. minutes, notes, or presentations) where the use or limitations of SuperScript IV were discussed. 3. Copies of any recorded correspondence (including emails or attachments) that are reasonably identifiable by reference to the document in point 1 and that: (a) transmit or attach that document; or (b) summarise or discuss concerns regarding the use of SuperScript IV in AML NPM1 MRD testing, limited to the period 1 August 2021 to 31 December 2021. 4. Please confirm: (a) the originating organisation responsible for the document; (b) whether it was received in draft or final form; (c) the approximate date it was first received or accessed. This request relates to technical and governance information only and does not seek personal data. If any information is withheld, please specify the exemption relied upon and the public interest reasoning. If the request exceeds the cost limit, please advise how it may be refined in accordance with section 16 of the Act. Toni please see the answer release that this FOI follow relates too- https://ouh.disclosurelog.co.uk/disclosures/13adb887-387c-4616-b961-b33175b2cba9

Response

REQUEST: Dear Freedom of Information Team,

Thank you for your email.

I write further to your response to FOI2026/00246.

In that response, the Trust stated:

“During an NHSE AML MRD subgroup meeting in September 2021… it was stated that Superscript IV should not be used… This was included in AML MRD minimal technical standards.”

As this indicates reliance on recorded information, I request disclosure of that information under the Freedom of Information Act 2000.

Please provide:

1. Copies of any recorded information and/or document described as, or equivalent to, “AML MRD minimal technical standards” (draft or final) in which this statement and/or equivalent guidance appears.

Data not held. We recommend contacting the Genomics Unit at NHSE directly.

 
2. Any recorded outputs from the NHS England AML MRD subgroup meeting in or around September 2021 (e.g. minutes, notes, or presentations) where the use or limitations of SuperScript IV were discussed.

Data not held. We recommend contacting the Genomics Unit at NHSE directly.

 

 

3. Copies of any recorded correspondence (including emails or attachments) that are reasonably identifiable by reference to the document in point 1 and that:
(a) transmit or attach that document; or
(b) summarise or discuss concerns regarding the use of SuperScript IV in AML NPM1 MRD testing,
limited to the period 1 August 2021 to 31 December 2021.

Data not held. We recommend contacting the Genomics Unit at NHSE directly.

4. Please confirm:
(a) the originating organisation responsible for the document; Genomics Unit at NHSE
(b) whether it was received in draft or final form; Final
(c) the approximate date it was first received or accessed. December 2021

Documents

There are no documents for this release.

This is Oxford University Hospitals NHS Foundation Trust's response to a freedom of information (FOI) or environmental information regulations (EIR) request.

You can browse our other responses or make a new FOI request.